Anti-high mobility group box 1 antibody suppresses local inflammatory reaction and facilitates olfactory nerve recovery following injury
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-high mobility group box 1 antibody suppresses local inflammatory reaction and facilitates olfactory nerve recovery following injury
Authors
Keywords
Astrocyte, Cycloheximide, Field potential recording, Head injury, HMGB1, Macrophage, Olfactory bulb, Olfactory nerve, Olfactory marker protein (OMP), Regeneration
Journal
Journal of Neuroinflammation
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-26
DOI
10.1186/s12974-018-1168-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibiting High-Mobility Group Box 1 (HMGB1) Attenuates Inflammatory Cytokine Expression and Neurological Deficit in Ischemic Brain Injury Following Cardiac Arrest in Rats
- (2016) Mei Xu et al. INFLAMMATION
- Anti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats
- (2016) Jun Haruma et al. Scientific Reports
- Tumor necrosis factor-α antagonists: Side effects and their management
- (2013) Sunil Dogra et al. Indian Journal of Dermatology Venereology & Leprology
- Blockade of interleukin-6 receptor suppresses inflammatory reaction and facilitates functional recovery following olfactory system injury
- (2013) Masayoshi Kobayashi et al. NEUROSCIENCE RESEARCH
- Anti-high mobility group box-1 antibody therapy for traumatic brain injury
- (2012) Yu Okuma et al. ANNALS OF NEUROLOGY
- High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes
- (2012) Peng-Cheng Ren et al. BRAIN RESEARCH BULLETIN
- HMGB1 in Development and Diseases of the Central Nervous System
- (2012) Ping Fang et al. MOLECULAR NEUROBIOLOGY
- HMGB1 as a therapeutic target in spinal cord injury: A hypothesis for novel therapy development
- (2011) KIYOSHI KIKUCHI et al. Experimental and Therapeutic Medicine
- Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures
- (2010) Mattia Maroso et al. NATURE MEDICINE
- High Mobility Group Box 1 Is Upregulated After Spinal Cord Injury and Is Associated With Neuronal Cell Apoptosis
- (2010) Hideyuki Kawabata et al. SPINE
- Olfactory Nerve Recovery Following Mild and Severe Injury and the Efficacy of Dexamethasone Treatment
- (2009) M. Kobayashi et al. CHEMICAL SENSES
- TNF-Alpha as a Therapeutic Target in Inflammatory Diseases, Ischemia- Reperfusion Injury and Trauma
- (2009) E. Esposito et al. CURRENT MEDICINAL CHEMISTRY
- Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage
- (2008) S. Muhammad et al. JOURNAL OF NEUROSCIENCE
- Predictors of prognosis in patients with olfactory disturbance
- (2007) Brian London et al. ANNALS OF NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now